Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Appropriate Antibiotic Use for Acute Otitis Media
Your Article Summary
See Latest ArticlesMicrovascular free tissue transfer after prior radiotherapy in head and neck reconstruction – A review
Surgical Oncology, 07/02/09
Thankappan K et al. - In a review of microvascular free tissue transfer after prior radiotherapy in head and neck reconstruction, this article examines existing evidence regarding the influence of prior radiotherapy on microvascular free tissue transfer and sets a platform for further studies in the current setting of organ preservation with chemoradiotherapy and surgical salvage.
Methods- Microvascular free tissue transfer has become an integral part of head and neck reconstruction.
- There are many reports on the influence of radiotherapy on the success of microvascular head and neck reconstruction, though there is a paucity of reports studying its effect after chemoradiotherapy.
- Laboratory studies on animals, though demonstrating considerable tissue damage, could not find any influence of radiotherapy on the patency of anastomosed vessels.
- Flap failure is reported to be more common after preoperative radiotherapy, but majority of studies could not demonstrate a significant difference due to lack of statistical power owing to the very high success rate of microvascular free-flap surgery.
- Operative complications increased as the time between radiotherapy and surgery increased.
- There are very few reports on outcome of free-flap reconstruction after the organ preservation regimens of chemoradiotherapy.
- Such outcome studies would be coming forth in the near future.
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: Results from a phase II prospective trial
Journal of Clinical Oncology, 11/25/09
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
The Lancet Oncology - Online First, 11/12/09
Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck
Annals of Oncology, 11/10/09
Article Search
Sponsor